7210 Wareham Drive, Tampa, FL 33647
October 17, 2024 According to State Health, the telehealth GLP-1 boom wouldn’t be possible without clinicians willing to write prescriptions for those hundreds of thousands of patients. Companies are rarely transparent — with patients or the public — about the medical groups behind the screens. But a STAT examination found that just a handful of networks of […]
Invisible Medical Groups Are Behind GLP-1 Boom Read More »
Sept. 23, 2024 According to Becker’s Hospital Review… On Sept. 24, Novo Nordisk CEO Lars Fruergaard Jørgensen is slated to testify at a Senate committee hearing about the costs for Wegovy and Ozempic. The hearing comes after months of disagreements between Denmark-based Novo Nordisk and the Senate Committee on Health, Education, Labor and Pensions. The
GLP-1 Drugs Market Update Read More »
Jan. 11, 2024 The pandemic had significant effects on the way commercial weight loss companies operate, along with the explosive demand for GLP-1 obesity drugs such as Ozempic, Wegovy, and Mounjaro. Marketdata estimates that between Medifast, Weight Watchers, Jenny Craig, and Noom, at least 26,500 weight loss coaches have lost their jobs since 2020. Here’s
Ozempic Boom Is Hurting Weight Loss Coaches Read More »
Feb. 3, 2022 As reported here and in many other publications, Noom’s rapid growth as a weight loss program is well known. The company may plan an IPO this year, and it’s estimated that revenues topped $600 million last year. The company has raised $669 million to date. However, there may be some weak spots.
Dec. 30, 2021 Jenny Craig has come out with it’s new program for 2022, called Max Up. The company claims that: “…While on the Max Up program, participants can lose up to 18 pounds* and 5 inches** off their waist size in the first four weeks. For the first time, Max Up participants complete a new digital
Jenny Craig’s New “Max Up” Program Read More »
Nov. 5, 2021 Medifast continued its momentum into the 3rd quarter and is poised to reach 2021 yearly sales of $1.5 billion, topping even Weight Watchers revenue to take over the lead for the first time. This is truly a remarkable feat, in light of the fact that Medifast has never run a national TV
Medifast Posts Strong Q3, Poised to Be #1 Weight Loss Firm Read More »
May 19, 2021 Noom Inc., a popular app targeted to help weight loss, is said to have obtained funding from the private equity firm Silver Lake ahead of a potential IPO. Noom is said to be worth $4 billion in its latest funding round, according to a Bloomberg report yesterday. The company, which hopes to be
Noom, Weight Loss App Company, Eyes Possible IPO Read More »
Feb. 26, 2021 Weight Watchers reported results of the 4th quarter and full tear 2020. Management said that: “…Our new membership tier, Digital 360, is being enthusiastically received by members and is building subscriber momentum. Today, WW is the leading weight loss and wellness digital subscription platform, with multiple membership verticals and revenue streams, creating
WW Reports Full Year 2020 Results Read More »
Jan. 16, 2019 J.P. Morgan analyst Christina Brathwaite recently downgraded WTW stock due to “channel check” that indicated falling interest in WW. She claims that traffic to the WW website is down year over year, spelling trouble for enrollments, and that the app Noom is providing competition. Well, I have a problem with this assessment.
Mystery J.P. Morgan Call on Weight Watchers – By J. LaRosa Read More »